河南省药品生产企业对新修订药品GMP认知和实施准备状况的调查  

Investigation on Cognition and Implementation of the Preparations of Pharmaceutical Manufacturers in Henan Province to the New Version of GMP

作　　者：宋丽丽[1] 高洁[1] 张志超[1] 

机构地区：[1]河南大学,开封475004

出　　处：《中国药事》2011年第11期1136-1139,共4页Chinese Pharmaceutical Affairs

基　　金：中国药学会药事管理委员会暨 "十二五药事管理学科发展与药品监管工作建设"学术研讨会获奖论文

摘　　要：目的了解药品生产企业对我国新修订药品GMP的认知和实施准备情况。方法采用非概率抽样法,按17%的比例对河南省药品生产企业进行抽样和问卷调查。结果与结论样本企业对新修订药品GMP的变化要点有较高的认知度,88.9%的样本企业对新修订药品GMP的要求可以承受,但需进行较大投入;样本企业在关键岗位人员、物料与产品管理、记录类文件管理、质量控制与质量保证等变化较大的关键环节,已不同程度地接近新标准要求,但需进一步强化、规范和改善。新修订药品GMP的新要求尤其是质量管理方面的新规定是实施的重点和难点。Objective To understand the cognition and implementation of the preparations of pharmaceutical manufacturers to the new version of GMP.Methods Non probability sampling methods was used to do questionnaire survey,the proportion of 17% sample of the pharmaceutical manufacturers in Henan Province.Results and Conclusion The sample enterprises have a higher awareness to the changes in the new version of GMP,88.9% of companies can afford requirements of the new version of GMP,but needing greater investment;the sample of enterprises,in key positions in personnel,materials and product management,record class document management,quality control and quality assurance and other key aspects greater changed,has different degrees approaching to the new standards,but needing further reinforcement,standardization and improvement.New requirements of the new version of GMP,especially the new provisions in quality management is important and difficult to execute regularly.

关 键 词：药品生产企业 新修订药品GMP 认知 实施准备 

分 类 号：R954.2[医药卫生—药学] TQ460.8[化学工程—制药化工]